| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 5.21e-11 | 431 | 234 | 25 | GO:0004984 |
| GeneOntologyMolecularFunction | odorant binding | OR5M9 OR9G1 OR8D2 OR4E2 OR14I1 OR8G5 OR8D4 OR9K2 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 | 3.29e-09 | 127 | 234 | 13 | GO:0005549 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5M9 OR9G1 OR8D2 ESR1 GPR82 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P BRS3 CCR7 OR8G5 OR7A17 OR8D4 GPR18 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 GRM5 OR8G2P OR12D3 ADGRG7 OR4A8 OR52N5 OR13C7 OR1L4 | 3.91e-09 | 884 | 234 | 33 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5M9 OR9G1 OR8D2 HLA-DQA1 ESR1 GPR82 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P BRS3 GLRB CCR7 OR8G5 OR7A17 OR8D4 ALK PLXNB1 GPR18 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 GRM5 OR8G2P OR12D3 ADGRG7 OR4A8 IGHM OR52N5 OR13C7 OR1L4 | 4.41e-07 | 1353 | 234 | 38 | GO:0004888 |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 1.79e-04 | 10 | 234 | 3 | GO:0140031 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 1.91e-11 | 432 | 230 | 25 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 9.17e-11 | 465 | 230 | 25 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 2.22e-10 | 485 | 230 | 25 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 1.10e-09 | 524 | 230 | 25 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 2.64e-09 | 547 | 230 | 25 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 9.15e-09 | 582 | 230 | 25 | GO:0050906 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADCY10 OR5M9 OR9G1 OR8D2 ESR1 GPR82 OR4E2 OR4D1 OR14I1 LMBRD2 OR2T11 OR13C6P USP20 OR10D4P PRKD3 BRS3 GLRB CCR7 OR8G5 OR7A17 OR8D4 PSAPL1 ALK GPR18 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 GRM5 OR8G2P OR12D3 ADGRG7 GTF2H2 OR4A8 OR52N5 OR13C7 OR1L4 | 1.02e-08 | 1395 | 230 | 41 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P NLRC4 OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 1.55e-07 | 722 | 230 | 26 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR5M9 OR9G1 OR8D2 ENPP1 OR4E2 OR4D1 OR14I1 OR2T11 OR13C6P OR10D4P GLRB KCNQ3 OR8G5 OR7A17 OR8D4 NIPBL OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 PKHD1L1 OR8G2P OR12D3 OR4A8 ELFN1 OR52N5 OR13C7 MCOLN3 OR1L4 | 3.74e-07 | 1072 | 230 | 32 | GO:0007600 |
| Domain | Olfact_rcpt | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR8G5 OR7A17 OR8D4 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR52N5 OR1L4 | 7.12e-08 | 393 | 226 | 20 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR5M9 OR9G1 OR8D2 GPR82 OR4E2 OR4D1 OR14I1 OR2T11 BRS3 CCR7 OR8G5 OR7A17 OR8D4 GPR18 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 OR8G2P OR12D3 OR52N5 OR1L4 | 6.22e-07 | 670 | 226 | 25 | IPR017452 |
| Domain | 7tm_1 | OR5M9 OR9G1 OR8D2 GPR82 OR4E2 OR4D1 OR14I1 OR2T11 BRS3 CCR7 OR8G5 OR7A17 OR8D4 GPR18 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 OR8G2P OR12D3 OR52N5 OR1L4 | 7.52e-07 | 677 | 226 | 25 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5M9 OR9G1 OR8D2 GPR82 OR4E2 OR4D1 OR14I1 OR2T11 BRS3 CCR7 OR8G5 OR7A17 OR8D4 GPR18 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 OR8G2P OR12D3 OR52N5 OR1L4 | 9.32e-07 | 685 | 226 | 25 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5M9 OR9G1 OR8D2 GPR82 OR4E2 OR4D1 OR14I1 OR2T11 BRS3 CCR7 OR8G5 OR7A17 OR8D4 GPR18 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 OR8G2P OR12D3 OR52N5 OR1L4 | 1.09e-06 | 691 | 226 | 25 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5M9 OR9G1 OR8D2 GPR82 OR4E2 OR4D1 OR14I1 OR2T11 BRS3 CCR7 OR8G5 OR7A17 OR8D4 GPR18 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 P2RY8 OR8G2P OR12D3 OR52N5 OR1L4 | 1.12e-06 | 692 | 226 | 25 | IPR000276 |
| Domain | Cyclin_D | 1.75e-06 | 3 | 226 | 3 | IPR015451 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.57e-05 | 15 | 226 | 4 | IPR002553 | |
| Domain | Adaptin_N | 2.57e-05 | 15 | 226 | 4 | PF01602 | |
| Domain | Coatomer/calthrin_app_sub_C | 9.36e-05 | 8 | 226 | 3 | IPR009028 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 1.46e-04 | 2 | 226 | 2 | IPR013037 | |
| Domain | - | 1.46e-04 | 2 | 226 | 2 | 2.60.40.1150 | |
| Domain | F-box | 1.58e-04 | 67 | 226 | 6 | PF00646 | |
| Domain | FBOX | 2.36e-04 | 72 | 226 | 6 | PS50181 | |
| Domain | F-box_dom | 2.95e-04 | 75 | 226 | 6 | IPR001810 | |
| Domain | IF5A_HYPUSINE | 4.34e-04 | 3 | 226 | 2 | PS00302 | |
| Domain | Transl_elong_IF5A_C | 4.34e-04 | 3 | 226 | 2 | IPR020189 | |
| Domain | Transl_elong_IF5A | 4.34e-04 | 3 | 226 | 2 | IPR001884 | |
| Domain | eIF-5a | 4.34e-04 | 3 | 226 | 2 | PF01287 | |
| Domain | AP_complex_bsu_1_2_4 | 4.34e-04 | 3 | 226 | 2 | IPR016342 | |
| Domain | Trans_elong_IF5A_hypusine_site | 4.34e-04 | 3 | 226 | 2 | IPR019769 | |
| Domain | B2-adapt-app_C | 4.34e-04 | 3 | 226 | 2 | PF09066 | |
| Domain | eIF-5a | 4.34e-04 | 3 | 226 | 2 | SM01376 | |
| Domain | KASH | 8.61e-04 | 4 | 226 | 2 | IPR012315 | |
| Domain | KASH | 8.61e-04 | 4 | 226 | 2 | PS51049 | |
| Domain | B2-adapt-app_C | 8.61e-04 | 4 | 226 | 2 | SM01020 | |
| Domain | GLTP | 8.61e-04 | 4 | 226 | 2 | PF08718 | |
| Domain | KASH | 8.61e-04 | 4 | 226 | 2 | SM01249 | |
| Domain | KASH | 8.61e-04 | 4 | 226 | 2 | PF10541 | |
| Domain | Glycolipid_transfer_prot_dom | 8.61e-04 | 4 | 226 | 2 | IPR014830 | |
| Domain | B-adaptin_app_sub_C | 8.61e-04 | 4 | 226 | 2 | IPR015151 | |
| Domain | Cyclin_C-dom | 1.05e-03 | 17 | 226 | 3 | IPR004367 | |
| Domain | Cyclin_C | 1.05e-03 | 17 | 226 | 3 | PF02984 | |
| Domain | Cyclin_C | 1.05e-03 | 17 | 226 | 3 | SM01332 | |
| Domain | CYCLIN | 1.12e-03 | 38 | 226 | 4 | SM00385 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR12D3 OR4A8 OR52N5 OR1L4 | 5.09e-08 | 417 | 175 | 21 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 OR8G5 OR7A17 OR8D4 OR9K2 OR4C6 OR5D14 OR9Q1 OR5B17 OR8G2P OR12D3 OR52N5 OR1L4 | 3.69e-07 | 389 | 175 | 19 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR14I1 OR2T11 KCNN2 OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR9Q1 OR5B17 OR12D3 OR4A8 OR52N5 OR1L4 | 1.31e-05 | 636 | 175 | 22 | M41834 |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 1.85e-05 | 5 | 175 | 3 | MM15696 | |
| Pathway | REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY | 1.85e-05 | 5 | 175 | 3 | M45016 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 6.35e-05 | 7 | 175 | 3 | MM15524 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S | 1.01e-04 | 8 | 175 | 3 | M47419 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483 | 1.50e-04 | 9 | 175 | 3 | M49010 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S | 2.12e-04 | 10 | 175 | 3 | M47418 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S | 2.88e-04 | 11 | 175 | 3 | M47426 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 2.78e-13 | 340 | 236 | 20 | 11875048 |
| Pubmed | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 2.78e-13 | 340 | 236 | 20 | 11802173 | |
| Pubmed | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 3.27e-13 | 343 | 236 | 20 | 32295537 | |
| Pubmed | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR2T35 OR4C6 OR5D14 OR9Q1 OR8G2P OR12D3 OR4A8 OR52N5 OR13C7 OR1L4 | 3.84e-13 | 346 | 236 | 20 | 14611657 | |
| Pubmed | Role of Fgf10 in cell proliferation in white adipose tissue. | 8.23e-11 | 6 | 236 | 5 | 16513252 | |
| Pubmed | OR5M9 OR9G1 OR8D2 OR4E2 OR4D1 OR2T11 OR10D4P OR8G5 OR7A17 OR8D4 OR9K2 OR4Q2 OR2T35 OR4C6 OR5D14 OR5B17 OR8G2P OR12D3 OR4A8 OR52N5 OR1L4 | 1.75e-10 | 541 | 236 | 21 | 14983052 | |
| Pubmed | TPP2 RGPD1 EDC4 DNAJC6 GDI1 FBXO2 STOX2 MDN1 AP1B1 AP2B1 SYNE2 FBXO41 NIPBL KPNB1 ANK2 KALRN SYNE1 DNM1L GRM5 YWHAG AKAP9 EIF4A2 UBA6 UNC13A PHLDB2 | 1.20e-08 | 963 | 236 | 25 | 28671696 | |
| Pubmed | GGNBP2 PIRT TTLL9 ATAD5 RGPD1 GDI1 RPRD1B CEP350 SLC38A1 MDN1 AP1B1 SYNE2 FGD5 NIPBL FAT4 ADAM30 INTS13 SMCR8 AHNAK2 | 9.20e-08 | 638 | 236 | 19 | 31182584 | |
| Pubmed | 3.09e-07 | 3 | 236 | 3 | 15576649 | ||
| Pubmed | Involvement of the D-type cyclins in germ cell proliferation and differentiation in the mouse. | 3.09e-07 | 3 | 236 | 3 | 11090462 | |
| Pubmed | Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. | 3.09e-07 | 3 | 236 | 3 | 15755896 | |
| Pubmed | Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis. | 3.09e-07 | 3 | 236 | 3 | 22289519 | |
| Pubmed | Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. | 3.09e-07 | 3 | 236 | 3 | 20090754 | |
| Pubmed | Crucial roles of D-type cyclins in the early stage of adipocyte differentiation. | 3.09e-07 | 3 | 236 | 3 | 18374658 | |
| Pubmed | Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. | 3.09e-07 | 3 | 236 | 3 | 17882269 | |
| Pubmed | Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. | 3.09e-07 | 3 | 236 | 3 | 22929040 | |
| Pubmed | Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. | 3.09e-07 | 3 | 236 | 3 | 15831479 | |
| Pubmed | 3.09e-07 | 3 | 236 | 3 | 9099742 | ||
| Pubmed | Characterization of a cluster comprising approximately 100 odorant receptor genes in mouse. | 4.20e-07 | 10 | 236 | 4 | 11130974 | |
| Pubmed | A2M GGNBP2 SAMD9 ENPP1 LMBRD2 DIP2A AP1B1 ANAPC2 UGDH ULK1 AP3D1 PLXNB1 MTMR12 DNAJC16 POLR3A SMG8 MARF1 PLCH1 | 5.82e-07 | 650 | 236 | 18 | 38777146 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 7.41e-07 | 74 | 236 | 7 | 15081110 | |
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 16287839 | ||
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 9603423 | ||
| Pubmed | Distinct patterns of expression of the D-type cyclins during testicular development in the mouse. | 1.23e-06 | 4 | 236 | 3 | 7537638 | |
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 24155149 | ||
| Pubmed | Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. | 1.23e-06 | 4 | 236 | 3 | 1827757 | |
| Pubmed | Negative regulation of TSC1-TSC2 by mammalian D-type cyclins. | 1.23e-06 | 4 | 236 | 3 | 16357142 | |
| Pubmed | Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. | 1.23e-06 | 4 | 236 | 3 | 8887674 | |
| Pubmed | Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. | 1.23e-06 | 4 | 236 | 3 | 24876129 | |
| Pubmed | A unique function for cyclin D3 in early B cell development. | 1.23e-06 | 4 | 236 | 3 | 16582912 | |
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 27129404 | ||
| Pubmed | 1.41e-06 | 13 | 236 | 4 | 12941628 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 25087893 | ||
| Pubmed | Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells. | 3.05e-06 | 5 | 236 | 3 | 11809706 | |
| Pubmed | Cyclin D2 in the basal process of neural progenitors is linked to non-equivalent cell fates. | 3.05e-06 | 5 | 236 | 3 | 22395070 | |
| Pubmed | Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. | 3.05e-06 | 5 | 236 | 3 | 1386336 | |
| Pubmed | Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. | 3.05e-06 | 5 | 236 | 3 | 1386335 | |
| Pubmed | Identification of G1 kinase activity for cdk6, a novel cyclin D partner. | 3.05e-06 | 5 | 236 | 3 | 8114739 | |
| Pubmed | A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95. | 3.05e-06 | 5 | 236 | 3 | 14641107 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 16954383 | ||
| Pubmed | In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3. | 3.05e-06 | 5 | 236 | 3 | 11311237 | |
| Pubmed | Schizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of cyclin D1. | 3.05e-06 | 5 | 236 | 3 | 27130439 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | A2M DNAJC6 AP1B1 AP2B1 UGDH BTRC KPNB1 MTMR12 DNAJC16 DUSP7 LAMB1 DNM1L ECPAS YWHAG LRRC1 EIF5A GEMIN4 ESPL1 SNTB1 PPTC7 PPP6R3 | 3.62e-06 | 974 | 236 | 21 | 28675297 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PDPK1 LYST PRKD3 AP1B1 AP2B1 ANAPC2 ULK1 BTRC CDC42BPA MAP4K3 RBL2 CBLB YWHAG CCND3 GTF2H2 IGF2 AKAP9 ESPL1 SNTB1 PPP6R3 | 4.70e-06 | 910 | 236 | 20 | 36736316 |
| Pubmed | Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. | 6.08e-06 | 6 | 236 | 3 | 37000627 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 12502747 | ||
| Pubmed | Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation. | 6.08e-06 | 6 | 236 | 3 | 16943274 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 9784491 | ||
| Pubmed | Growth suppression by p16ink4 requires functional retinoblastoma protein. | 6.08e-06 | 6 | 236 | 3 | 7603984 | |
| Pubmed | STAT3 down-regulates the expression of cyclin D during liver development. | 6.08e-06 | 6 | 236 | 3 | 12147685 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 10380928 | ||
| Pubmed | CDK4 activity in mouse embryos expressing a single D-type cyclin. | 6.08e-06 | 6 | 236 | 3 | 18311721 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 17362983 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 11360184 | ||
| Pubmed | G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells. | 6.08e-06 | 6 | 236 | 3 | 28192421 | |
| Pubmed | The GATA2 transcription factor negatively regulates the proliferation of neuronal progenitors. | 1.06e-05 | 7 | 236 | 3 | 16672344 | |
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 11042687 | ||
| Pubmed | Early embryonic death in mice lacking the beta-catenin-binding protein Duplin. | 1.06e-05 | 7 | 236 | 3 | 15367660 | |
| Pubmed | Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. | 1.06e-05 | 7 | 236 | 3 | 11134518 | |
| Pubmed | p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. | 1.06e-05 | 7 | 236 | 3 | 8033213 | |
| Pubmed | 1.13e-05 | 21 | 236 | 4 | 28107452 | ||
| Pubmed | TPP2 EDC4 GDI1 TASOR2 DHX8 WDR3 MDN1 AP1B1 AP2B1 SYNE2 NIPBL KPNB1 ECPAS THOC2 GEMIN4 PPP6R3 | 1.16e-05 | 653 | 236 | 16 | 22586326 | |
| Pubmed | PRAMEF10 AOC1 RPRD1B TEX264 ARHGEF6 PLXNB1 PRAMEF33 ZWILCH MAP4K3 DNM1L PRAMEF17 RPP14 THOC2 CCND2 MTA1 SETD5 INTS13 EIF4A2 ESPL1 DEDD VPS13B | 1.81e-05 | 1084 | 236 | 21 | 11544199 | |
| Pubmed | GGNBP2 RGPD1 LYST TASOR2 MDN1 AP2B1 TCHHL1 SYNE2 ATP11C ULK1 USP1 NIPBL AP3D1 KPNB1 ANK2 SYNE1 TEX14 YWHAG SETD5 EIF4A2 MARF1 PLCH1 POLQ RBFA CFAP46 | 1.85e-05 | 1442 | 236 | 25 | 35575683 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | A2M PDPK1 ESRRG DHX33 DHX8 CEP350 KCNN2 KPNB1 RBL2 CCND2 CCND3 GTF2H2 AKAP9 LRRC1 MEPCE MCOLN3 | 2.47e-05 | 695 | 236 | 16 | 23602568 |
| Pubmed | Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. | 2.51e-05 | 9 | 236 | 3 | 24793136 | |
| Pubmed | Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. | 2.51e-05 | 9 | 236 | 3 | 15467835 | |
| Pubmed | Array MAPPIT: high-throughput interactome analysis in mammalian cells. | 2.75e-05 | 26 | 236 | 4 | 19159283 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EDC4 LYST CEP350 FSIP2 STOX2 MDN1 SYNE2 MTMR12 KRT78 CDC42BPA DNM1L YWHAG AKAP9 MEPCE PLCH1 EDRF1 PHLDB2 AHNAK2 | 2.75e-05 | 861 | 236 | 18 | 36931259 |
| Pubmed | Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. | 3.57e-05 | 10 | 236 | 3 | 10944119 | |
| Pubmed | jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. | 3.57e-05 | 10 | 236 | 3 | 12852854 | |
| Pubmed | The LxCxE pRb interaction domain of cyclin D1 is dispensable for murine development. | 3.57e-05 | 10 | 236 | 3 | 17699765 | |
| Pubmed | β-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesis. | 3.57e-05 | 10 | 236 | 3 | 21108844 | |
| Pubmed | Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. | 3.57e-05 | 10 | 236 | 3 | 29160310 | |
| Pubmed | A2M GGNBP2 TASOR2 BRDT RTTN LAMB1 CBLB CTDNEP1 MTPAP LRRC1 GEMIN4 POLQ PHLDB2 | 3.92e-05 | 496 | 236 | 13 | 31343991 | |
| Pubmed | ESRRG KLHL41 PRKD3 SYNE2 UGDH USP1 KPNB1 CDC42BPA ANK2 KALRN SYNE1 AKAP9 GYG1 | 4.00e-05 | 497 | 236 | 13 | 23414517 | |
| Pubmed | Effects of Pparγ1 deletion on late-stage murine embryogenesis and cells that undergo endocycle. | 4.30e-05 | 29 | 236 | 4 | 34246625 | |
| Pubmed | CCND1 AP1B1 AP2B1 BRDT ULK1 CDC42BPA MAP4K3 DNM1L ADAM30 YWHAG POLR3A CCND2 CCND3 KLK4 SETD5 UBA6 | 4.44e-05 | 730 | 236 | 16 | 34857952 | |
| Pubmed | The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression. | 4.59e-05 | 2 | 236 | 2 | 33123289 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 16818732 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 24594358 | ||
| Pubmed | Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. | 4.59e-05 | 2 | 236 | 2 | 21357542 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 11792814 | ||
| Pubmed | Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation. | 4.59e-05 | 2 | 236 | 2 | 31130465 | |
| Pubmed | Interaction between the pRb2/p130 C-terminal domain and the N-terminal portion of cyclin D3. | 4.59e-05 | 2 | 236 | 2 | 10572252 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 20164373 | ||
| Pubmed | CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. | 4.59e-05 | 2 | 236 | 2 | 30538135 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 25239130 | ||
| Pubmed | CDK-independent activation of estrogen receptor by cyclin D1. | 4.59e-05 | 2 | 236 | 2 | 9039267 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 20056644 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 23051957 | ||
| Pubmed | Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis. | 4.59e-05 | 2 | 236 | 2 | 16983339 | |
| Pubmed | Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. | 4.59e-05 | 2 | 236 | 2 | 11726322 | |
| Pubmed | Genetic replacement of cyclin D1 function in mouse development by cyclin D2. | 4.59e-05 | 2 | 236 | 2 | 15657434 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 36937431 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 38459884 | ||
| Pubmed | A non-canonical role for the EDC4 decapping factor in regulating MARF1-mediated mRNA decay. | 4.59e-05 | 2 | 236 | 2 | 32510323 | |
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 10398124 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 22214766 | ||
| Pubmed | 4.59e-05 | 2 | 236 | 2 | 16884382 | ||
| GeneFamily | Cyclins|F-boxes other | 4.10e-04 | 39 | 163 | 4 | 560 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 4.79e-04 | 4 | 163 | 2 | 1252 | |
| GeneFamily | Olfactory receptors, family 8 | 9.84e-04 | 49 | 163 | 4 | 155 | |
| GeneFamily | Olfactory receptors, family 9 | 1.12e-03 | 23 | 163 | 3 | 156 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-07 | 200 | 232 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-07 | 200 | 232 | 10 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SLC9A9 KLF9 FGF10 NNMT FAT4 ANK2 SYNE1 LAMB1 ADAMTSL3 PHLDB2 | 1.05e-07 | 200 | 232 | 10 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.77e-07 | 185 | 232 | 9 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.60e-07 | 188 | 232 | 9 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | background-B_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.54e-07 | 191 | 232 | 9 | a189fdc9c739bb0801e2f38af0932a1ea615cb34 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.54e-07 | 191 | 232 | 9 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 7.87e-07 | 192 | 232 | 9 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.22e-07 | 193 | 232 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | SLC38A1 STOX2 TM4SF18 NNMT KALRN ADAMTSL3 PKHD1L1 LRRC1 PHLDB2 | 8.96e-07 | 195 | 232 | 9 | e91ce548ae7224661ee5d2f2639794a5f69798ee |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 9.35e-07 | 196 | 232 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 9.35e-07 | 196 | 232 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.35e-07 | 196 | 232 | 9 | 0175b097ad1338a07afebe3b5c7fd0bb0bb950f7 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.62e-07 | 145 | 232 | 8 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.75e-07 | 197 | 232 | 9 | 2e9677b4b9a7c88db16416e5f114a2031ec3bc24 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.75e-07 | 197 | 232 | 9 | 4c9919914079e76b1d2220b249e0d0b0d9bf4bc0 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-06 | 199 | 232 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-06 | 200 | 232 | 9 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.32e-06 | 163 | 232 | 8 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.76e-06 | 174 | 232 | 8 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-06 | 174 | 232 | 8 | fde40c5d51f5380088360dc5a583eb04e518deb6 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.92e-06 | 175 | 232 | 8 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 175 | 232 | 8 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-06 | 176 | 232 | 8 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 180 | 232 | 8 | 711719219bcbafdd505790eda895e7a33f21bed2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 181 | 232 | 8 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.24e-06 | 182 | 232 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.68e-06 | 184 | 232 | 8 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-06 | 185 | 232 | 8 | 191d7e9b34bd1598cb4c18e0cb3d018bad83c757 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-06 | 185 | 232 | 8 | 99fe59c15c3c0f7afa7e182255e4bacfba346132 | |
| ToppCell | (1)_B_CD27neg|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.15e-06 | 186 | 232 | 8 | 646389147189760e9493c4f50f9583959ef0ee26 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-06 | 186 | 232 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.15e-06 | 186 | 232 | 8 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.65e-06 | 188 | 232 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 6.91e-06 | 189 | 232 | 8 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 6.91e-06 | 189 | 232 | 8 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.91e-06 | 189 | 232 | 8 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 6.91e-06 | 189 | 232 | 8 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-06 | 190 | 232 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 7.47e-06 | 191 | 232 | 8 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-06 | 191 | 232 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-06 | 191 | 232 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-06 | 191 | 232 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 7.47e-06 | 191 | 232 | 8 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.76e-06 | 192 | 232 | 8 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 8.06e-06 | 193 | 232 | 8 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-06 | 193 | 232 | 8 | 8d88f3b0d08f9dbae26ee122dbd43f06e2cc3f67 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.06e-06 | 193 | 232 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.06e-06 | 193 | 232 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.37e-06 | 194 | 232 | 8 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.69e-06 | 195 | 232 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.69e-06 | 195 | 232 | 8 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.69e-06 | 195 | 232 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.69e-06 | 195 | 232 | 8 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 8.69e-06 | 195 | 232 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.69e-06 | 195 | 232 | 8 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.69e-06 | 195 | 232 | 8 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.01e-06 | 196 | 232 | 8 | c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-06 | 196 | 232 | 8 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.01e-06 | 196 | 232 | 8 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 9.01e-06 | 196 | 232 | 8 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-06 | 196 | 232 | 8 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 9.36e-06 | 197 | 232 | 8 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.36e-06 | 197 | 232 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.36e-06 | 197 | 232 | 8 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 197 | 232 | 8 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.36e-06 | 197 | 232 | 8 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.36e-06 | 197 | 232 | 8 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 9.71e-06 | 198 | 232 | 8 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.71e-06 | 198 | 232 | 8 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.71e-06 | 198 | 232 | 8 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.01e-05 | 199 | 232 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.01e-05 | 199 | 232 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | (2)_B_cell-(23)_Follicular_B_cell|(2)_B_cell / shred on Cell_type and subtype | 1.01e-05 | 199 | 232 | 8 | da661933bfa43ad7069a4bc75aef6a72ccd5796e | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 232 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | mLN-B_cell-Follicular_B_cell|mLN / Region, Cell class and subclass | 1.04e-05 | 200 | 232 | 8 | 7f5dbd06f8643230dba45d6fa0258a13cb71f681 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 232 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | mLN-(2)_B_cell-(23)_Follicular_B_cell|mLN / shred on region, Cell_type, and subtype | 1.04e-05 | 200 | 232 | 8 | 659b49eeeb3e96b0a52663e60336ca4d76c83cfc | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 232 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Caecum-B_cell-Follicular_B_cell|B_cell / Region, Cell class and subclass | 1.04e-05 | 200 | 232 | 8 | eadd81db68e437f873472aa47017c22d5a307655 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.04e-05 | 200 | 232 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 150 | 232 | 7 | d6b977dd47aa017f6ba762f0c505cd896caa523f | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 1.52e-05 | 152 | 232 | 7 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 152 | 232 | 7 | b8aa62e3cf2b4c252db4bccfa75d881c4fa0a788 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-05 | 152 | 232 | 7 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 159 | 232 | 7 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-05 | 163 | 232 | 7 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-05 | 164 | 232 | 7 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-05 | 165 | 232 | 7 | 83095377aedf960c05baa523869bdbd2b0a05f2d | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-05 | 165 | 232 | 7 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 167 | 232 | 7 | 691f3589de0f8c13f9137812cfa9040c07d237b4 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 167 | 232 | 7 | 4520ee71e2b119c1dfa0e342fe57eda5f3598650 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.89e-05 | 168 | 232 | 7 | b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-05 | 169 | 232 | 7 | d382a76d85875663502cc7dde2e3e0682605768e | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 170 | 232 | 7 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | URO-Lymphocyte-B-B_intermediate|URO / Disease, Lineage and Cell Type | 3.12e-05 | 170 | 232 | 7 | e11d1510518cedabeece96d4adbb90999e6326fa | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.12e-05 | 170 | 232 | 7 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.24e-05 | 171 | 232 | 7 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.24e-05 | 171 | 232 | 7 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| Disease | Malignant neoplasm of breast | KLK10 PDPK1 ESR1 CCND1 SYNE2 FGF10 FGD5 NIPBL ALK PLEKHA8 PLXNB1 ANK2 KALRN SYNE1 MCOLN1 OR12D3 CUTC AKAP9 EIF4A2 ZFYVE26 VPS13B | 5.21e-05 | 1074 | 218 | 21 | C0006142 |
| Disease | Albinism | 5.43e-05 | 2 | 218 | 2 | C0001916 | |
| Disease | mucolipidosis type IV (implicated_via_orthology) | 1.62e-04 | 3 | 218 | 2 | DOID:0080490 (implicated_via_orthology) | |
| Disease | calcium measurement | ESRRG CCND1 SLC38A1 KLF9 SYNE2 RTL9 EXOC3L2 OR7A17 BANK1 ZWILCH MAP4K3 CCND2 ILDR1 POLQ | 2.62e-04 | 628 | 218 | 14 | EFO_0004838 |
| Disease | immature platelet measurement | 2.63e-04 | 119 | 218 | 6 | EFO_0803541 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.23e-04 | 4 | 218 | 2 | cv:CN293514 | |
| Disease | invasive lobular carcinoma (is_implicated_in) | 3.23e-04 | 4 | 218 | 2 | DOID:3457 (is_implicated_in) | |
| Disease | glycoproteinosis (implicated_via_orthology) | 3.23e-04 | 4 | 218 | 2 | DOID:3343 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 5.35e-04 | 5 | 218 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 5.35e-04 | 5 | 218 | 2 | C0410190 | |
| Disease | blood pressure | 5.52e-04 | 22 | 218 | 3 | EFO_0004325 | |
| Disease | blood urea nitrogen measurement | GGNBP2 HLA-DQA1 ESRRG DHX8 USP38 CDC42BPA CCND3 IGF2 TTC21B ILDR1 MBD5 | 5.82e-04 | 452 | 218 | 11 | EFO_0004741 |
| Disease | platelet measurement | 5.96e-04 | 315 | 218 | 9 | EFO_0005036 | |
| Disease | asthma exacerbation measurement | 6.45e-04 | 93 | 218 | 5 | EFO_0007614 | |
| Disease | systemic scleroderma (is_implicated_in) | 7.18e-04 | 24 | 218 | 3 | DOID:418 (is_implicated_in) | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.99e-04 | 6 | 218 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.99e-04 | 6 | 218 | 2 | C0410189 | |
| Disease | azoospermia (implicated_via_orthology) | 1.02e-03 | 27 | 218 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.11e-03 | 7 | 218 | 2 | C0751337 | |
| Disease | colon adenoma (is_marker_for) | 1.11e-03 | 7 | 218 | 2 | DOID:0050912 (is_marker_for) | |
| Disease | immature platelet count | 1.16e-03 | 106 | 218 | 5 | EFO_0803544 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.37e-03 | 222 | 218 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | male breast carcinoma | 1.48e-03 | 8 | 218 | 2 | EFO_0006861 | |
| Disease | Cornelia De Lange Syndrome | 1.48e-03 | 8 | 218 | 2 | C0270972 | |
| Disease | immature platelet fraction | 1.61e-03 | 114 | 218 | 5 | EFO_0009187 | |
| Disease | Uterine leiomyoma, breast carcinoma | 1.68e-03 | 32 | 218 | 3 | EFO_0000305, HP_0000131 | |
| Disease | prostate cancer (is_implicated_in) | 1.80e-03 | 117 | 218 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | androsterone sulfate measurement | 1.84e-03 | 33 | 218 | 3 | EFO_0021117 | |
| Disease | lupus nephritis | 1.84e-03 | 33 | 218 | 3 | EFO_0005761 | |
| Disease | Hydrocephalus | 1.89e-03 | 9 | 218 | 2 | C0020255 | |
| Disease | lifestyle measurement, systolic blood pressure | 1.89e-03 | 9 | 218 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | lean body mass | 2.15e-03 | 379 | 218 | 9 | EFO_0004995 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.34e-03 | 181 | 218 | 6 | DOID:684 (is_implicated_in) | |
| Disease | multiple myeloma (is_marker_for) | 2.37e-03 | 36 | 218 | 3 | DOID:9538 (is_marker_for) | |
| Disease | heel bone mineral density, urate measurement | 2.40e-03 | 182 | 218 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | aortic measurement | 2.74e-03 | 251 | 218 | 7 | EFO_0020865 | |
| Disease | body weights and measures | 2.77e-03 | 38 | 218 | 3 | EFO_0004324 | |
| Disease | diffuse scleroderma (is_implicated_in) | 2.86e-03 | 11 | 218 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | birth weight, parental genotype effect measurement | 3.13e-03 | 192 | 218 | 6 | EFO_0004344, EFO_0005939 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.42e-03 | 12 | 218 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 3.42e-03 | 12 | 218 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | N-acetylputrescine measurement | 3.42e-03 | 12 | 218 | 2 | EFO_0800127 | |
| Disease | stomach carcinoma (is_implicated_in) | 3.42e-03 | 12 | 218 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.62e-03 | 264 | 218 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | autistic disorder (is_implicated_in) | 3.69e-03 | 42 | 218 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | ascending aortic diameter | 3.91e-03 | 140 | 218 | 5 | EFO_0021787 | |
| Disease | mean platelet volume | SLC9A9 AOC1 ATAD5 SLFN14 AP1B1 AP2B1 KLF9 SYNE2 EXOC3L2 BANK1 KALRN OR9Q1 RTTN DNM1L MCOLN1 ESPL1 | 3.94e-03 | 1020 | 218 | 16 | EFO_0004584 |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 3.95e-03 | 43 | 218 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 4.02e-03 | 13 | 218 | 2 | C3501611 | |
| Disease | Malignant neoplasm of liver | 4.16e-03 | 142 | 218 | 5 | C0345904 | |
| Disease | Liver neoplasms | 4.16e-03 | 142 | 218 | 5 | C0023903 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 4.66e-03 | 14 | 218 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 4.66e-03 | 14 | 218 | 2 | EFO_0020941 | |
| Disease | serum metabolite measurement | AOC1 SLC22A11 ERMP1 SLC38A1 SYNE2 USP1 ALK CDC42BPA DNAJC16 LAMB1 CCND3 MTA1 IGF2 SNTB1 PPP6R3 | 4.67e-03 | 945 | 218 | 15 | EFO_0005653 |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 4.78e-03 | 46 | 218 | 3 | EFO_0005325, HP_0012735 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 5.35e-03 | 15 | 218 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | non-dense area measurement, mammographic density measurement | 5.35e-03 | 15 | 218 | 2 | EFO_0005941, EFO_0006504 | |
| Disease | Rhabdomyosarcoma | 5.35e-03 | 15 | 218 | 2 | C0035412 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.71e-03 | 49 | 218 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | fetal genotype effect measurement, body weights and measures | 5.71e-03 | 49 | 218 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | eye morphology measurement | 5.79e-03 | 218 | 218 | 6 | EFO_0007858 | |
| Disease | Romano-Ward Syndrome | 6.09e-03 | 16 | 218 | 2 | C0035828 | |
| Disease | Blood Platelet Disorders | 6.09e-03 | 16 | 218 | 2 | C0005818 | |
| Disease | Colorectal Carcinoma | CCND1 ATP11C ANK2 KALRN SYNE1 ARFGEF1 ADAMTSL3 CCND2 IGF2 AKAP9 INTS13 EDRF1 | 6.27e-03 | 702 | 218 | 12 | C0009402 |
| Disease | muscular dystrophy (is_implicated_in) | 6.87e-03 | 17 | 218 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | high altitude adaptation | 6.87e-03 | 17 | 218 | 2 | EFO_0009105 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 6.87e-03 | 17 | 218 | 2 | OBA_2045173 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECLSQYPSLSQLKEL | 311 | A0A0G2JMD5 | |
| VSIIEEDKNSYTPCL | 1056 | Q9UPW8 | |
| VELTDLSTCYPRIIS | 871 | Q9BXT4 | |
| KQDVSLCSLLALIYA | 66 | Q7Z4L5 | |
| VVTLLCGVKSSDQLY | 111 | Q8NDB2 | |
| LSLLDNYLIKNCSET | 101 | P61981 | |
| LTANTCDIRKSILYL | 1386 | Q96QE3 | |
| LPDTYISKTIALVNC | 116 | Q2M3D2 | |
| STVSAKDLELTQCYK | 2506 | Q99996 | |
| DLKYNLSAEGISCIT | 771 | Q9P2K9 | |
| SILSKLQSVCTEDSY | 241 | P0C7U0 | |
| DAQILKVIEAYCTSA | 656 | Q15052 | |
| TTPLTIEKLCIYTDH | 116 | P30281 | |
| CVSTLLDLIQTKVNY | 391 | P63010 | |
| VNTCDIITLYISAIK | 391 | Q9UJX6 | |
| ATLLQLITKFATEYC | 331 | O00429 | |
| ASTLRELEKYVSACL | 561 | Q58F21 | |
| VSTSLDCLQKLIAYG | 96 | Q9Y6D6 | |
| DSTPATCLKISDIIY | 166 | Q14330 | |
| ILSYLDAKSLCAAEL | 196 | Q9Y297 | |
| YCEKSVTPDTALSLE | 4196 | Q6V0I7 | |
| LVSCSVESAAKIYPE | 66 | Q9UNA3 | |
| STCELSKQLNIAYDV | 296 | P32248 | |
| SYSCPEEVLSVLKQD | 1426 | Q8IYW2 | |
| DSVCITVDYKLPRTV | 576 | Q8TC27 | |
| TIPLTAEKLCIYTDN | 116 | P24385 | |
| CVSTLLDLIQTKVNY | 391 | Q10567 | |
| LGSIICDIKFSELTY | 241 | O75618 | |
| CSLSLYGEIELQKVT | 121 | Q96K78 | |
| LDLNVSCISKELDSY | 711 | Q96PN6 | |
| PLAVTKYRESELCSS | 621 | P19801 | |
| SSSCVLTSILYLGEK | 56 | Q5T3Y7 | |
| ESTDIASCPTLLVYV | 146 | Q8TCP9 | |
| LTLLPSAEESYDCKV | 176 | P01909 | |
| SVCLYGTATVAKIIL | 491 | Q7Z2K6 | |
| TETTEKGCVLLSYLN | 41 | P01023 | |
| KGCVLLSYLNETVTV | 46 | P01023 | |
| TYRDELLTKIIDICS | 391 | O14617 | |
| ESLTELPLVEKFSYC | 856 | Q9UPM8 | |
| YKALTDLLCTPEVSQ | 101 | Q8N0V3 | |
| CTLAEKYGLLAVLET | 146 | A4D1S5 | |
| YTPKILVTCISEDKS | 76 | Q8NH87 | |
| GVLLLYDVTCEKSFL | 616 | Q8IZ41 | |
| KVCLDLSAEYLILSD | 411 | Q6P2E9 | |
| LVAAVETLCKITEYQ | 126 | Q9NVM9 | |
| SCSSTYINELLVLVL | 201 | Q6IF36 | |
| VDFCYSSIVTPKLLE | 71 | Q8NGL3 | |
| ACYTATILKLLRTEE | 211 | Q86VZ1 | |
| DYCTLVTIAKSLLDL | 56 | Q13886 | |
| SVVSEEVCSKLYDPL | 171 | Q9Y5K2 | |
| EAKNLASYDVCSILL | 376 | Q9GZU1 | |
| YVSLTRILKCSEQSL | 111 | Q08999 | |
| CNLNITLPIYTKESE | 1446 | Q01484 | |
| SPLTAEKLCIYTDNS | 116 | P30279 | |
| VCSSYEVDTKLLSLI | 126 | Q8N635 | |
| PELSKVASLCYSLVT | 291 | Q8NGE7 | |
| IVPLIKLSCSSTYID | 181 | Q8NGM9 | |
| KLSCSSTYIDELLIF | 186 | Q8NGM9 | |
| KLSCSSTYINELLIL | 221 | Q8NG78 | |
| GEIKASSAVLCLSYL | 261 | Q5XUX1 | |
| KYLCGALQTSIVLLE | 686 | Q8IVH8 | |
| LILVSYTCIGISISK | 211 | Q8NGN7 | |
| DICYTTSSVPLILDS | 71 | Q8NH95 | |
| DICYTTSSVPLILDS | 71 | P0DN81 | |
| KLTCGESYTQEVLII | 186 | Q8NGQ5 | |
| LSFIDLCYSSVITPK | 66 | Q9GZM6 | |
| SYVLVESVCKSLQTL | 301 | Q9NU22 | |
| ECLSQYPSLSQLKEL | 311 | Q5VTA0 | |
| EVSSCIPKILAEESY | 196 | Q9NVX0 | |
| DTPVVKSSSRELCYI | 606 | P41594 | |
| YLIETKNILTCLASA | 286 | Q96P67 | |
| SDCKYEPLATLSTDV | 256 | P17735 | |
| LLELYTEKRSTVACA | 141 | O95711 | |
| VNEDVLLTTGLLCKY | 416 | Q9NPP4 | |
| QTPEYDVVLCLSLTK | 571 | Q7L2J0 | |
| EIQAKSLTSYDVCSI | 361 | Q8TDD5 | |
| LIDSSCLLETLETYL | 196 | Q9H3C7 | |
| LLCEASTVLKYVQED | 51 | Q9C0I1 | |
| IVKLYDLTTLCEETE | 431 | Q3B7T1 | |
| YSLALKCLISLSTII | 166 | Q9H2S1 | |
| CLILAVLTTFKEYET | 136 | O43525 | |
| LKSTIDLTCNDYISV | 216 | Q13191 | |
| EVISELLCKILYAFS | 4951 | Q5CZC0 | |
| AEILLETCKSITYSL | 1761 | Q5VYK3 | |
| SDAGCLYELTVKLLS | 211 | Q9UK22 | |
| KTSLSFYDCVAVTEL | 621 | O43157 | |
| VCLKSIILLNSGVYT | 446 | P03372 | |
| KDKITCDLYQLISPS | 301 | Q6PJ61 | |
| AIPEYISCLKQALTE | 51 | Q53H82 | |
| DLCYSTVTTPKLLAD | 71 | P0C623 | |
| LDLTSLSYKILIFVC | 216 | Q9HCR9 | |
| PTIYQLLSACESFKE | 66 | P40261 | |
| KVPYALKIETSESCL | 1171 | Q6ZNL6 | |
| IILKCDYTTSAQLQD | 41 | Q86SU0 | |
| KLVTYLASVPSEDVC | 76 | O60229 | |
| LYNKVCDIVSSLSEL | 1386 | Q6KC79 | |
| YCVVLLTAETTKLSK | 386 | Q9Y2G8 | |
| KDLQTEASLDSVLCY | 406 | O60662 | |
| RLLCEYQELTSTKLS | 391 | Q8N1N4 | |
| SLSAVKDLVCSIVYQ | 81 | O94806 | |
| LLKDISQKVAVYSTC | 1771 | P07942 | |
| KYDCGEEILITVLSA | 126 | P63241 | |
| SECTTLAAELPKVSY | 311 | P48167 | |
| DPNTYKVLSLVLSVC | 71 | P22413 | |
| ALVISGDSLEVCLKY | 726 | O75110 | |
| TVAELLSLACYIASL | 981 | O75110 | |
| NSLYLKSAEIDCSIS | 241 | Q96JA3 | |
| TTAEAECTDIKILPY | 46 | Q9H3R1 | |
| IPAVLKLSCTDTSLY | 181 | Q8NGX2 | |
| EENTKLRYLTCSLIE | 201 | Q9NVV4 | |
| DTDYTTGEKILTCVL | 401 | Q9BTT6 | |
| CLDISYSSVTLPKLL | 66 | Q9UGF7 | |
| IGILTTSYCELLQNK | 116 | Q8NI37 | |
| TSLEVSLLEKYPCSK | 56 | O95456 | |
| KDERISCLEAYVTLT | 6 | Q4G163 | |
| STAYLQICSLKAEDT | 96 | A0A0J9YVY3 | |
| KVCSLEYAGSVSTLL | 311 | Q9UKF2 | |
| LDQTTDTYLLLSLTC | 846 | Q14674 | |
| KYDCGEEILITVLSA | 126 | Q6IS14 | |
| LVKDTCSYVNVLSDL | 266 | P46976 | |
| ESTKEPSLLQYLCVQ | 696 | Q96AV8 | |
| KLTCLVTDLTTYDSV | 241 | P01871 | |
| TLETRDCKPFYTIDL | 246 | P61567 | |
| LQLVTKVDCETTPIY | 521 | Q6ZTQ4 | |
| PVRKLYDDCSSTIVE | 96 | P62508 | |
| YKILLLSCGISLEQS | 1971 | O75417 | |
| DLALLETYCATPAKS | 76 | P01344 | |
| TARSKCLTETPIEYL | 331 | Q92819 | |
| DVLIGETKIYSTCTD | 256 | O75061 | |
| NLYAEASEKLCTPLL | 2706 | Q5VT06 | |
| SDSLLRKYSCVILDE | 181 | Q9H6R0 | |
| TRCKAATVLLYDEAT | 126 | Q16829 | |
| YNLEDIISATITPLC | 601 | Q0VDD8 | |
| SSECIYNLIPSDLKE | 6 | Q8TC29 | |
| LDTLCDLYETLTITQ | 261 | Q14240 | |
| TEEITSLFVCKPYSI | 3616 | Q99698 | |
| TYCLSSSFELIVQKL | 496 | Q14974 | |
| ETLYILSKTNSICDG | 36 | Q8TF61 | |
| DYDVSSISALTQKLC | 1376 | Q9Y4F3 | |
| GSLLSCLEQVKTYLL | 41 | Q9P267 | |
| LSCSEYSLKVTDVTK | 246 | Q9NTM9 | |
| VGETLLCQLSSYAKT | 111 | Q9H9L4 | |
| LVTEKASVYCVAAVL | 521 | Q76NI1 | |
| TKKENCPYSILEITS | 101 | O15520 | |
| PCLETVNRIKLYSES | 201 | P31150 | |
| LASYSVIDKQDLITC | 181 | Q96PD2 | |
| CLTALDTTGKAVYTL | 351 | Q14689 | |
| SCSDTDVPYLLLAVK | 141 | Q7Z7M8 | |
| FGISLTCLTIYKAEL | 441 | Q9NSA0 | |
| EYLSLVSKVCTELDN | 26 | Q14562 | |
| LALIDLCYSTVTSPK | 66 | Q15615 | |
| VLKLACADTSLYETL | 181 | Q8NH01 | |
| CCISLSYTLILKAAI | 221 | Q8NH56 | |
| TGLLIEDKAISYSAC | 81 | Q8NGF7 | |
| SCVVQTLKEYLESLQ | 196 | P0DJD0 | |
| NICVEIYTSLEKASI | 151 | Q6NXP6 | |
| FLSETKIISYVGCLI | 86 | Q8NGR5 | |
| LKNLSVLDLCYISVT | 61 | A6ND48 | |
| YSTTISPVLIVDLLC | 71 | P0C604 | |
| ILIASYTVILCSLKS | 211 | Q8NH72 | |
| CILKEILQEYLEISS | 221 | P07332 | |
| SKVLYLLLTSICDNS | 146 | Q8ND04 | |
| SLKELIDRSLYTECQ | 1296 | Q8NET4 | |
| ICVKYLSGLLEVITS | 1291 | Q86VV8 | |
| SLYLKSAEIDCSISS | 126 | O95397 | |
| TCDPSNIYDLIKTLK | 176 | Q6P1K8 | |
| EKLLYECTISASSPL | 396 | Q8IUD6 | |
| YESLTASVQSDLKLC | 656 | Q68CJ6 | |
| AELIAEISTACTYKN | 436 | Q13884 | |
| SITKECIILVDTYSP | 331 | Q6NUJ1 | |
| LSKTVDEACLLLAEY | 226 | Q9NQG5 | |
| ILYVCESDSLKDFVT | 621 | P0C7P3 | |
| STTEEYLISKCVLDL | 726 | Q8IWB6 | |
| EVTCTPYLKETLNSI | 501 | Q9UKY4 | |
| YDCVKLTFSPSTLLV | 81 | Q8IVB4 | |
| AVPIKICSSATETYK | 1576 | Q8NF91 | |
| SLLQLSTCDVESKRY | 5121 | Q8WXH0 | |
| ILPLDVSTTIYNRCK | 51 | Q68DH5 | |
| THLNPSTEYKICIDI | 581 | Q9H3W5 | |
| GTYSTILIKTEVIEC | 961 | Q5K651 | |
| VITCLAYTLKLSDKS | 71 | P0C851 | |
| AQYVSPELLTEKSAC | 246 | O15530 | |
| ILTCTLGYVTLLEET | 71 | Q9BVG9 | |
| VKSLEDLCSQYDLTV | 876 | O14802 | |
| LCIYAVSAITKDAEV | 371 | Q9C0A6 | |
| LVGILCSYSKIVSSI | 211 | O14581 | |
| YSLKEALCDPTVASR | 251 | Q9BRX2 | |
| LICESKSVAGLTLTY | 381 | G3V0H7 | |
| CSVTLLNETESLKSY | 126 | Q13330 | |
| ENLLSETKTISYVGC | 81 | Q8NGP3 | |
| ETILSLCAEYTKPDS | 451 | Q86SQ0 | |
| DAICAVEISSKEYLL | 1411 | Q5VT25 | |
| VEISSKEYLLCFNSI | 1416 | Q5VT25 | |
| YTSILDLDNKTLRCP | 806 | Q8TEV9 | |
| ESCTSYPVSKKLLQE | 201 | P32247 | |
| SLDCYLTISGEDKIL | 631 | Q9UM73 | |
| SSILSPCEDVTLTKY | 4781 | Q8IVF2 | |
| CTLELGSYIKDLSVV | 161 | O95476 | |
| ILLTKAAVCTTLKYV | 301 | Q8NB49 | |
| TDLSFLDKYQCVVLT | 146 | A0AVT1 | |
| VSRLVTISKDPYEAC | 391 | O60701 | |
| LTEYSTLTLCQETLA | 801 | Q8N2E2 | |
| EYGTSIEDILSVLKC | 876 | Q8N2E2 | |
| IKAELTSSAPACYAL | 566 | Q04724 | |
| SVLSCDISVDDKYIV | 741 | Q04724 | |
| SITGIVLYVVSCKAD | 161 | Q9H900 | |
| TVKEDILLSVEYSCH | 46 | A8MXK1 | |
| VLACLYLVSDTVLKE | 111 | Q8NI27 | |
| IRDSKLSDSATYLCV | 96 | A0A0B4J245 | |
| KCIELLYAALTSSST | 176 | Q8N8B7 | |
| KLACTDTYLTGILIV | 186 | Q8NGC2 | |
| SENCSKKYVTLLSII | 81 | Q96CE8 | |
| TCDPSNIYDLIKTLK | 176 | Q13888 | |
| AEICLYAATSDLRKT | 366 | C9JQI7 | |
| ISSTSYKEVCIPEIV | 546 | Q9P2F5 | |
| QSSLKYEDLAPCITL | 776 | P29144 | |
| ESCSISPKLRSIAVY | 66 | Q9Y6I9 | |
| ECLSQYPSLSQLKEL | 311 | O60809 | |
| YCLVTSRLQKILAES | 241 | Q6ZMU5 | |
| TCIDLLDLVRTKYTG | 791 | Q86WI1 | |
| KVLSVNYTAIECETS | 1701 | Q86WI1 | |
| KGQSVISLDLYTCEL | 821 | Q9NYK1 | |
| EASCTKLVPYLLSSV | 831 | Q8NB14 | |
| LAKECTSQITTYDLL | 616 | Q9Y2K6 | |
| KLCRELSDLVVYTNS | 596 | Q4KWH8 | |
| AYENTTIDNLCSIKL | 461 | Q8NEG5 | |
| LTASSQEDYELKTCL | 346 | Q3SXZ7 | |
| ETALTVLDTYCKIST | 291 | Q8NA56 | |
| QIICSYLSQSIELKV | 2731 | Q7Z7G8 | |
| AKYVSINSTLESCEL | 821 | Q5VWN6 | |
| KALSVLRYITDCVDS | 186 | O75800 | |
| LNLCYLDIKSLLSSE | 81 | Q5QJ38 | |
| VSLLDCTVKIFYVDT | 566 | Q9UNX4 | |
| YEEKTLSAILRICSS | 66 | O95059 | |
| YKSPSELLEICELSQ | 311 | Q9NRG4 | |
| KYPNISCELLTSDVS | 76 | Q5H9R7 | |
| LVTCIDYQTLFDPKS | 616 | Q92547 | |
| LCDSYISKVDVLNIL | 2001 | Q68DK2 | |
| IYSINLLLICSKETG | 116 | Q9H2H9 | |
| ELYKASVVSCQGLSL | 941 | O75385 | |
| TKDSCLPKEIYEVTS | 86 | A8MQ14 | |
| KEDSLASYELICSLQ | 136 | O94782 | |
| ASYELICSLQSLIIS | 141 | O94782 | |
| INILCDLITPSEATY | 1211 | P82987 | |
| LETLTCYETLSKTNP | 1006 | P57678 | |
| SSITILSPKECEVFY | 191 | O43240 |